Sense of drug welfare acquisition and its influencing factors in patients with chronic diseases under the background of centralized drug purchasing
- VernacularTitle:药品集中采购背景下慢性病患者药品福利获得感及影响因素
- Author:
Yun XU
1
;
Shaoliang TANG
1
Author Information
1. School of Health Economics and Management，Nanjing University of Chinese Medicine，Nanjing 210046，China
- Publication Type:Journal Article
- Keywords:
drug welfare;
centralized drug purchasing;
patients with chronic diseases;
consumer surplus;
ordered Logit
- From:
China Pharmacy
2022;33(19):2418-2422
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To study the sense of drug welfare acquisition and its influencing factors in patients with chronic diseases under the background of centralized drug purchasing . METHODS Based on the theory of consumer surplus ，questionnaire survey and analysis were performed about the sense of drug welfare acquisition in patients with chronic diseases under the background of centralized drug purchasing . The ordered Logit regression model was established to investigate the influencing factors for the sense of drug welfare acquisition . RESULTS & CONCLUSIONS A total of 285 questionnaires were distributed and 285 were recovered ，of which 215 were valid （the effective rate was 75.4%）. The results of the questionnaire survey showed that ， influenced by factors such as chronic disease outpatient subsidies and drug buying habits ，the sense of drug welfare acquisition in chronic disease patients under the centralized drug purchasing mode had been significantly improved slightly ，and the age ， education level ，monthly income and medical insurance type had significant impact on the sense of drug welfare acquisition （P＜ 0.01 or P＜0.05）. Compared with the drop of drug price brought about by centralized drug purchasing ，the sense of drug welfare acquisition in chronic disease patients has been improved slightly . The centralized drug purchasing is mainly to further increase the drug welfare for patients with chronic diseases with the help of medical insurance overall planning . Our country should strengthen the assessment of selected drugs in public hospitals ；promote drug consistency evaluation to increase the trust of patients to selected drugs ；develop pharmaceutical services with the help of medical consortium and hierarchical diagnosis and treatment platform to increase the drug welfare of patients with chronic diseases.
